ImportRefusal LogoImportRefusal

Glaxo Smith Kline Consumer

⚠️ Moderate Risk

FEI: 3006742011 • Agbara, Ng-Og • NIGERIA

FEI

FEI Number

3006742011

📍

Location

Agbara, Ng-Og

🇳🇬

Country

NIGERIA
🏢

Address

Nig Plc Igbesa Road, , Agbara, Ng-Og, Nigeria

Moderate Risk

FDA Import Risk Assessment

34.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
3
Unique Violations
3/10/2021
Latest Refusal
4/29/2008
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
2.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
3/10/2021
63RBJ04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
3280FRNMFGREG
Division of Northeast Imports (DNEI)
3/25/2011
60LCB01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/29/2008
60LBR01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Glaxo Smith Kline Consumer's FDA import refusal history?

Glaxo Smith Kline Consumer (FEI: 3006742011) has 3 FDA import refusal record(s) in our database, spanning from 4/29/2008 to 3/10/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo Smith Kline Consumer's FEI number is 3006742011.

What types of violations has Glaxo Smith Kline Consumer received?

Glaxo Smith Kline Consumer has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxo Smith Kline Consumer come from?

All FDA import refusal data for Glaxo Smith Kline Consumer is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.